BTIG analyst Justin Zelin has reiterated their bullish stance on MRSN stock, giving a Buy rating yesterday.Stay Ahead of the Market:Discover ...

As per the filing, Biogen has a 10.2% stake in Sage Therapeutics. The offer price, representing a 30% premium to the stock's ...

Jefferies analyst Dennis Ding maintained a Hold rating on Crinetics Pharmaceuticals (CRNX – Research Report) today and set a price target of ...

The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...

This case concerns a very common practice of deducting the employer national insurance contributions (ER NIC) from the fee ...

If you want to boost your gut health and avoid chronic conditions, you may want to consider including vegetables with certain ...

In his regular column, Dr James Le Fanu answers your questions. This week, a reader asks whether her overactive bladder ...

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...

Ukraine's long-range drone strikes on airbases and ammunition depots inside Russia have reduced the glide-bomb threat.

As flu hospitalisations continue to rise, we ask the experts why this winter is particularly bad and what we can do to stay ...

Innovation in the sector is driven by the healthcare industry's advancements, shaped by emerging therapeutic modalities and ...

Bill Detwiler of Celonis shares how Process Intelligence can deliver insights into juvenile justice, which can drive policy ...